Experts have received €29 million (£24m) to investigate serious lung infections that particularly affect babies and older people.
Diseases caused by respiratory syncytial virus (RSV) are estimated to affect more than 30 million children under five each year throughout the world.
The virus also affects older people and those with weakened immune systems, including cancer patients and people with chronic lung diseases such as emphysema.